Woman’s death will be focus of 2nd Xarelto Trial

Woman’s death will be focus of 2nd Xarelto Trial

Woman's death will be focus of 2nd Xarelto Trial

A month after drugmakers Johnson & Johnson and Bayer prevailed in the first trial over allegations of harm caused by the blood thinner Xarelto, the second bellwether case has gone to trial in New Orleans.

This time, the family of a woman who died about a year after she started taking the drug for atrial fibrillation is accusing the drugmakers of responsibility for her fatal hemorrhagic stroke.

Sharyn Orr, of Louisiana, died in May 2015 at the age of 67 after being in a coma for 10 days.

The family’s lawyers say her death was “completely avoidable.”


About TriMark

TriMark Legal Funding provides non-recourse pre-settlement and post-settlement Xarelto lawsuit loans to injured plaintiffs nationwide.

This post originally appeared here: https://www.drugwatch.com/news/2017/06/09/xarelto-second-trial-avoidable-death/

Click here to see the full original article.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408